Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 16

1.

The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer.

Gross CP, McAvay GJ, Guo Z, Tinetti ME.

Cancer. 2007 Jun 15;109(12):2410-9.

2.

Use of adjuvant systemic therapy for early breast cancer among women 65 years of age and older.

Balasubramanian BA, Gandhi SK, Demissie K, August DA, Kohler B, Osinubi OY, Rhoads GG.

Cancer Control. 2007 Jan;14(1):63-8.

3.

Diabetes mellitus and breast cancer: a retrospective population-based cohort study.

Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE.

Breast Cancer Res Treat. 2006 Aug;98(3):349-56. Epub 2006 Mar 16.

PMID:
16541321
4.

Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy.

Hurria A, Brogan K, Panageas KS, Pearce C, Norton L, Jakubowski A, Zauderer M, Howard J, Hudis C.

Breast Cancer Res Treat. 2005 Jul;92(2):151-6.

PMID:
15986124
5.

Do patients consistently report comorbid conditions over time?: results from the prostate cancer outcomes study.

Klabunde CN, Reeve BB, Harlan LC, Davis WW, Potosky AL.

Med Care. 2005 Apr;43(4):391-400.

PMID:
15778642
6.

Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma.

Cristofanilli M, Yamamura Y, Kau SW, Bevers T, Strom S, Patangan M, Hsu L, Krishnamurthy S, Theriault RL, Hortobagyi GN.

Cancer. 2005 Mar 15;103(6):1122-8.

7.

Stroke risk and tamoxifen therapy for breast cancer.

Geiger AM, Fischberg GM, Chen W, Bernstein L.

J Natl Cancer Inst. 2004 Oct 20;96(20):1528-36.

8.

Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States.

Harlan LC, Clegg LX, Trimble EL.

J Clin Oncol. 2003 Sep 15;21(18):3488-94.

PMID:
12972525
9.

Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study.

Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, Manson JE; Nurses' Health Study.

Diabetes Care. 2003 Jun;26(6):1752-8.

PMID:
12766105
10.

Adiposity and sex hormones in postmenopausal breast cancer survivors.

McTiernan A, Rajan KB, Tworoger SS, Irwin M, Bernstein L, Baumgartner R, Gilliland F, Stanczyk FZ, Yasui Y, Ballard-Barbash R.

J Clin Oncol. 2003 May 15;21(10):1961-6.

11.

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.

Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW.

JAMA. 2001 Feb 21;285(7):885-92.

PMID:
11180731
12.

Comorbidity and breast cancer survival: a comparison between black and white women.

West DW, Satariano WA, Ragland DR, Hiatt RA.

Ann Epidemiol. 1996 Sep;6(5):413-9.

PMID:
8915472
13.

Factors associated with surgical and radiation therapy for early stage breast cancer in older women.

Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG.

J Natl Cancer Inst. 1996 Jun 5;88(11):716-26.

14.

The effect of comorbidity on 3-year survival of women with primary breast cancer.

Satariano WA, Ragland DR.

Ann Intern Med. 1994 Jan 15;120(2):104-10.

PMID:
8256968
15.

Patterns of care related to age of breast cancer patients.

Greenfield S, Blanco DM, Elashoff RM, Ganz PA.

JAMA. 1987 May 22-29;257(20):2766-70.

PMID:
3573271
16.

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Charlson ME, Pompei P, Ales KL, MacKenzie CR.

J Chronic Dis. 1987;40(5):373-83.

PMID:
3558716
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk